510(k) K234015
K234015 is an FDA 510(k) premarket notification submitted by Eusa Pharma (Uk) Limited for the device "Caphosol® Artifical Saliva (32 doses sachet box)". The FDA issued a decision of Substantially Equivalent on March 11, 2024. The device falls under product code LFD (Saliva, Artificial), a Class U device. Eusa Pharma (Uk) Limited has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 11, 2024
- Date Received
- December 19, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Saliva, Artificial
- Device Class
- Class U
- Regulation Number
- Review Panel
- DE
- Submission Type